MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Bio-Rad Laboratories Cash and Cash Equivalents 2011-2026 | BIO
Annual Cash and Cash Equivalents Bio-Rad Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 488 M | 404 M | 434 M | 471 M | 662 M | 661 M | 432 M | 384 M | 456 M | 458 M | 413 M | 332 M | 463 M | 574 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 662 M | 332 M | 474 M |
Quarterly Cash and Cash Equivalents Bio-Rad Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 369 M | 521 M | 410 M | 407 M | 433 M | 458 M | 390 M | 464 M | 434 M | 518 M | 597 M | 802 M | 471 M | 860 M | 733 M | 673 M | 662 M | 662 M | 662 M | 662 M | 661 M | 661 M | 661 M | 661 M | 432 M | 432 M | 432 M | 432 M | 384 M | 384 M | 384 M | 384 M | 456 M | 456 M | 456 M | 456 M | 458 M | 458 M | 458 M | 458 M | 413 M | 413 M | 413 M | 413 M | 332 M | 332 M | 332 M | 332 M | 463 M | 463 M | 463 M | 463 M | 574 M | 574 M | 574 M | 574 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 860 M | 332 M | 498 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
27.6 M | $ 31.63 | 2.03 % | $ 1.4 B |  USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
Boston Scientific Corporation
BSX
|
414 M | $ 95.41 | 0.76 % | $ 140 B | USA |
 |
Abiomed
ABMD
|
233 M | - | - | $ 17.2 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
139 M | $ 21.25 | 2.36 % | $ 3.04 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
43.7 M | $ 3.6 | 2.86 % | $ 125 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
78.6 M | $ 9.15 | 2.81 % | $ 657 M |  Israel |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
24.5 M | $ 42.12 | 3.97 % | $ 1.3 B | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
183 M | $ 50.6 | 5.18 % | $ 7.54 K | USA |
 |
EDAP TMS S.A.
EDAP
|
24.7 M | $ 3.48 | 2.35 % | $ 130 M |  France |
 |
Abbott Laboratories
ABT
|
7.62 B | $ 126.37 | 1.76 % | $ 220 B | USA |
 |
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
15.3 M | $ 28.03 | 2.34 % | $ 237 M | USA |
 |
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
InMode Ltd.
INMD
|
68.9 M | $ 15.27 | 3.18 % | $ 1.21 B | Israel |
 |
IRadimed Corporation
IRMD
|
52.2 M | $ 98.11 | 2.73 % | $ 1.24 B | USA |
 |
Align Technology
ALGN
|
1.04 B | $ 160.18 | 2.66 % | $ 12 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
43.8 M | $ 18.13 | 3.22 % | $ 418 M | USA |
 |
Accuray Incorporated
ARAY
|
57.4 M | $ 0.89 | 4.38 % | $ 91.5 M | USA |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
20.1 M | $ 14.34 | 2.21 % | $ 388 M | USA |
 |
FONAR Corporation
FONR
|
46.8 M | $ 18.52 | 0.03 % | $ 121 M | USA |
 |
LivaNova PLC
LIVN
|
429 M | $ 63.29 | 4.37 % | $ 3.43 B |  Britain |
|
LENSAR
LNSR
|
16.3 M | $ 11.32 | -2.5 % | $ 130 M | USA |
 |
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | USA |
 |
IRIDEX Corporation
IRIX
|
7.03 M | $ 1.21 | 3.42 % | $ 19.5 M | USA |
 |
Globus Medical
GMED
|
784 M | $ 90.81 | 4.02 % | $ 12.3 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 12.56 | 4.58 % | $ 967 M | USA |
 |
Aziyo Biologics
AZYO
|
19.3 M | - | 1.37 % | $ 20.5 M | USA |
 |
Establishment Labs Holdings
ESTA
|
90.3 M | $ 65.25 | -5.21 % | $ 1.84 B |  Costa-rica |